Michael Merz

Pharmacology, Toxicology and PharmaceuticsMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “A novel phenotype‐based drug‐induced liver injury causality assessment tool (DILI‐CAT) allows for signal confirmation in early drug development”.

A novel phenotype‐based drug‐induced liver injury causality assessment tool (DILI‐CAT) allows for signal confirmation in early drug development

Alimentary Pharmacology & Therapeutics(2022)10.1111/apt.16836

N/A

0DataRank · unranked

9 citations

Don C. Rockey, Ayako Suzuki, Michael Merz, Hans L. Tillmann, Richard Hermann

A novel quantitative computer-assisted drug-induced liver injury causality assessment tool (DILI-CAT)

PLoS ONE(2022)10.1371/journal.pone.0271304

N/A

0DataRank · unranked

5 citations

Ayako Suzuki, Michael Merz, Richard Hermann, Don C. Rockey, Hans L. Tillmann